Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease

[Figure: see text]

Detalles Bibliográficos
Autores principales: Naylor, Kyla L., McArthur, Eric, Dixon, Stephanie N., Kwong, Jeffrey C., Thomas, Doneal, Balamchi, Shabnam, Blake, Peter G., Garg, Amit X., Atiquzzaman, Mohammad, Hladunewich, Michelle A., Levin, Adeera, Yeung, Angie, Oliver, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier, Inc., on behalf of the International Society of Nephrology. 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886430/
https://www.ncbi.nlm.nih.gov/pubmed/36731610
http://dx.doi.org/10.1016/j.kint.2023.01.009
Descripción
Sumario:[Figure: see text]

Ejemplares similares